Post-Marketing Safety of Bimekizumab in Psoriasis Patients: Pharmacovigilance Data From FDA Adverse Event Reporting System
用户AuN2r47E68qo
7个月前
88
10
已关闭
DOI:
文献链接:
其他信息:
